Steven R Hall
Overview
Explore the profile of Steven R Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dawson C, Bartlett K, Wilkinson M, Ainsworth S, Albulescu L, Kazandijan T, et al.
PLoS Negl Trop Dis
. 2024 Oct;
18(10):e0012570.
PMID: 39423239
Background: Variation in snake venoms is well documented, both between and within species, with intraspecific venom variation often correlated with geographically distinct populations. The puff adder, Bitis arietans, is widely...
2.
Du T, Hall S, Chung F, Kurdyukov S, Crittenden E, Patel K, et al.
Sci Transl Med
. 2024 Jul;
16(756):eadk4802.
PMID: 39018365
Snakebites affect about 1.8 million people annually. The current standard of care involves antibody-based antivenoms, which can be difficult to access and are generally not effective against local tissue injury,...
3.
Bartlett K, Hall S, Rasmussen S, Crittenden E, Dawson C, Albulescu L, et al.
Proc Natl Acad Sci U S A
. 2024 Apr;
121(19):e2315597121.
PMID: 38687786
Snakebite envenoming is a neglected tropical disease that causes substantial mortality and morbidity globally. The venom of African spitting cobras often causes permanent injury via tissue-destructive dermonecrosis at the bite...
4.
Yap M, Modahl C, Hall S
Front Pharmacol
. 2024 Mar;
15:1380193.
PMID: 38434707
No abstract available.
5.
Hall S, Rasmussen S, Crittenden E, Dawson C, Bartlett K, Westhorpe A, et al.
Nat Commun
. 2023 Dec;
14(1):7812.
PMID: 38097534
Morbidity from snakebite envenoming affects approximately 400,000 people annually. Tissue damage at the bite-site often leaves victims with catastrophic life-long injuries and is largely untreatable by current antivenoms. Repurposed small...
6.
Laprade W, Bartlett K, Christensen C, Kazandjian T, Patel R, Crittenden E, et al.
Sci Rep
. 2023 Dec;
13(1):21662.
PMID: 38066189
Snakebite envenoming is a global public health issue that causes significant morbidity and mortality, particularly in low-income regions of the world. The clinical manifestations of envenomings vary depending on the...
7.
McKeown B, Relja N, Hall S, Gebremeskel S, MacLeod J, Veinotte C, et al.
Can J Physiol Pharmacol
. 2023 Feb;
101(4):214.
PMID: 36847292
No abstract available.
8.
Ahmadi S, Pachis S, Kalogeropoulos K, McGeoghan F, Canbay V, Hall S, et al.
Toxicon
. 2022 Oct;
220:106955.
PMID: 36309071
Snakebite envenoming was reintroduced as a Category A Neglected Tropical Disease by the World Health Organization in 2017. Since then, increased attention has been directed towards this affliction and towards...
9.
Menzies S, Litschka-Koen T, Edge R, Alsolaiss J, Crittenden E, Hall S, et al.
PLoS Negl Trop Dis
. 2022 Sep;
16(9):e0010496.
PMID: 36108067
Background: Snakebite is a major public health concern in Eswatini, where treatment relies upon one antivenom-SAIMR Polyvalent. Although effective in treating snakebite, SAIMR Polyvalent is difficult to source outside its...
10.
McKeown B, Relja N, Hall S, Gebremeskel S, MacLeod J, Veinotte C, et al.
Can J Physiol Pharmacol
. 2022 Aug;
100(11):1065-1076.
PMID: 35985040
Despite numerous therapeutic options, multidrug resistance (MDR) remains an obstacle to successful breast cancer therapy. Jadomycin B, a natural product derived from ISP5230, maintains cytotoxicity in MDR human breast cancer...